Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound
Public ClinicalTrials.gov record NCT04176627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
* As studied previously, lung congestion is very prevalent however usually asymptomatic in dialysis patients. Fluid overload is associated with hospitalizations, worse cardiovascular outcomes and mortality in PD patients. * The clinical exam is the only tool used currently to monitor volume status of PD patients, and has been found to have poor sensitivity and specificity for lung congestion compared to lung ultrasound. In current practice, patients are seen and examined monthly at their home dialysis units by the nurses. The nephrologist separately examines the patient monthly, possibly days to weeks after the nurse visit, and potentially only quarterly with the use of telehealth visits. * Lung ultrasound is a relatively simple and cheap tool to assess for lung congestion, with little inter-operator variability and good reproducibility. * There are limited studies of lung ultrasound in peritoneal dialysis, and none in the United States. Lung ultrasound may be useful as an objective measure of lung congestion in patients without signs or symptoms of fluid overload. Aims of this study * This study aims to determine the prevalence of subclinical fluid overload in peritoneal dialysis patients. * The investigators aim to determine the added benefit of lung ultrasound to standard clinical practice of fluid management in PD patients. * The investigators aim to assess the association of patient characteristics with lung congestion. * The investigators also aim to assess the agreement between nurse physical exam and lung ultrasound for fluid overload.
Study identification
- NCT ID
- NCT04176627
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 44 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2019
- Primary completion
- Mar 31, 2020
- Completion
- Jun 29, 2020
- Last update posted
- Aug 13, 2020
2019 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 1
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| WellBound Daly City | Daly City | California | 94014 | — |
| Satellite WellBound Emeryville | Emeryville | California | 94608 | — |
| Satellite WellBound Fremont | Fremont | California | 94538 | — |
| Satellite WellBound Milpitas | Milpitas | California | 95035 | — |
| WellBound Modesto | Modesto | California | 95345 | — |
| WellBound North Modesto | Modesto | California | 95356 | — |
| Satellite WellBound Mountain View | Mountain View | California | 94040 | — |
| WellBound Sacramento | Sacramento | California | 95821 | — |
| WellBound San Francisco | San Francisco | California | 94109 | — |
| Satellite WellBound San Jose | San Jose | California | 95125 | — |
| WellBound San Leandro | San Leandro | California | 94577 | — |
| Satellite WellBound San Mateo | San Mateo | California | 94403 | — |
| Wellbound Santa Cruz | Santa Cruz | California | 95062 | — |
| WellBound Santa Rosa | Santa Rosa | California | 95407 | — |
| WellBound Stockton | Stockton | California | 95219 | — |
| WellBound Vallejo | Vallejo | California | 94590 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04176627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04176627 live on ClinicalTrials.gov.